Team

BOARD OF DIRECTORS

Dario Neri
Co-founder and President of the Scientific Advisory Board of Philogen. He graduated in Chemistry at the Scuola Normale Superiore in Pisa and obtained his PhD in Chemistry from the ETH Zurich, under the supervision of Prof. Kurt Wüthrich, winner of the Nobel Prize for Chemistry, 2002.  For his dissertation, he was awarded the Silver Medal of ETH. After a 5 year post-doctoral research position in the lab of Sir Gregory Winter at the Cambridge Centre of Protein Engineering in Cambridge, UK, he returned to the ETH Zurich in 1996 as Assistant Professor in Molecular Structure Biology.  Since 1999, he has been a Professor in Biomacromolecules in the department of Chemistry and Applied Biosciences, (ETH). 

He is the recipient of the ISOBM Abbott Prize 2000, of the Amgen-Dompe’ Biotec Award 2000, of the Mangia d’Oro 2001, of the Prous Award 2006 of the European Federation of Medicinal Chemistry, of the Robert-Wenner-Prize 2007 of the Swiss Cancer League, of the SWISS BRIDGE Award 2008 and of the Prix Mentzer 2011 of the French Medicinal Chemistry Society. Prof. Neri is author of more than 200 publications in international journals.

Eugenio Aringhieri 
Vice President of Philogen S.p.A.. After graduating in Pharmacy at the University of Pisa, Eugenio Aringhieri worked 11 years with multinational pharmaceutical companies.  In 1995 he joined the group Dompé Farmaceutici S.p.A., acting as the Marketing and Sales Director for Italy.  He successively held the General Manager position at Dompé Biotec, as well as other companies belonging to Dompé Farmaceutici S.p.A., operating both in Italy and abroad. Since 2005, he has been the CEO of the group Dompé Farmaceutici S.p.A. His responsibilities coincide with the steady growth and continuous strengthening of its managerial and organizational structure, making it fully integrated in order to carry out its activities in the development of specialized medicine, and to focus its research on the identification of new drugs for the treatment of rare diseases. 
In full agreement with its shareholders, Eugenio Aringhieri led the consolidation process of the trade agreements with Biogen Idec and Amgen, the world's leading biotechnological research companies, in a strategic partnership through the formation of the joint venture Biogen Dompé and Amgen Dompé; now the Italian leaders in the development of new bio-therapeutic products for unmet medical needs. In conjunction with his role as Director, Eugenio Aringhieri carries out the commitment of the group Dompé Farmaceutici S.p.A. regarding the promotion of pharmaceutical and biotechnological development, while continuing to hold an important role within the pharmaceutical sector, on the national and European level.

Giovanni Neri 
Co-founder and Director of IP & Licensing at Philogen S.p.A. Giovanni Neri graduated in Biology at the University of Siena where he also received his doctorate in Biotechnology.  He later specialized in antibody therapeutics in clinical oncology at the Royal Postgraduate Medical School at the Hammersmith Hospital, London (1993-1995). As Director, he is responsible for developing the company's patent portfolio and is involved in the conclusion of all the major contractual agreements.

Dario Neri
Co-founder and Scientific Director of Philogen S.p.A. He graduated in Chemistry at the Scuola Normale Superiore in Pisa. Dario Neri is the silver medalist for the best doctorial thesis at ETH Zurich, under the supervision of Prof. Kurt Wüthrich, winner of the Nobel Prize for Chemistry, 2002.  After a 5 year post-doctoral research position in the lab of Sir Gregory Winter at the Cambridge Centre of Protein Engineering in Cambridge, UK, he returned to ETH Zurich in 1996 as Assistant Professor in Molecular Structure Biology.  Since 1999, he has been a Professor in Biomacromolecules in the department of Applied Chemistry Biosciences, (ETH). 
In 2000, Prof. Neri won the Abbott Award from the International Society of Oncodevelopmental Biology & Medicine, as well as the Biotec Award.  In 2006 he won theProus Award from the European Society of Chemical Medicine, and the Robert Wenner Price award in 2007. Prof. Neri is author of more than 200 publications in international journals.

Sergio Gianfranco Luigi Maria Dompé 
Sergio Dompé obtained three honorary degrees(pharmaceutical biotechnology from the University of Bologna in 1996, medical biotechnology from the University of L’Aquila in 2005 and pharmacy from the University of Urbino in 2010), as a result of his commitment to the pharmaceutical industry. In 1976, he started working for Dompé Farmaceutici S.p.A., founded by his father in 1940, and right from the start, brought many changes to the company’s strategy. He was among the first entrepreneurs in the industry to believe strongly in the opportunities offered by biotechnology for the development of new drugs. On the basis of this intuition, he established partnerships with global pharmaceutical companies to provide patients with new therapeutic benefits. Sergio Dompé holds the office of Chairman of Dompé Farmaceutici S.p.A., holding company of Dompé Group, which operates through three different companies, Dompé, Amgen Dompé and Biogen Dompé, and employs 800 persons globally and registered a turnover of 529.4 million Euros in 2010. From 1998 to 2004, Sergio Dompé was Chairman of Assobiotech for three consecutive terms in office. In June 2005 he was appointed President of Farmindustria, the Italian Pharmaceutical Companies’ Association and member of the Confindustria Council. Since January 2006, he has been Chairman of the Assessment Committee of the CNR (Italian Research Council). Since July 2007 he has been member of the Council of the Italian Institute of Technology foundation.

Roberto Marsella 
Roberto Marsalla graduated in Business Economics at the Universita Commerciale "Lugi Bocconi in Milan, and later obtained an MBA from the Stern School of Business in New York. Extensive experience in investment banking & corporate finance in Italy and abroad gave way to his current position as Chairman of Tuctos, a corporate advisory firm. Roberto Marsella is also currently active in investment advising in small and medium businesses, as well as Vice Chairman of Finance for Philogen S.p.A.

BOARD OF AUDITORS
• Pier Luigi Matteoni 
• Giorgio Cantini 
• Stefano Mecacci